Beruflich Dokumente
Kultur Dokumente
Page 26-1
Page 26-2
Page 26-3
Appendix A
Site Study Closeout Checklist
To be completed by the Site PI and Study Coordinator
Site:
Protocol:
Marking Complete means that all versions of the following essential documents are present and up-to-date
or items are completed as stated
Marking N/A means that the listed item is Not Applicable for the Protocol (if marked, explain why in the
Notes section)
Complete
N/A
Notes
I CRF/DATA Completeness
A. All data collection is completed through the last
participants last follow-up.
B. All CRFs are complete, including data that
requires transcription from source materials.
C. All study data has been entered into the DEMS.
D. All SAEs have been followed until conclusion or
acceptable resolution.
E. All Oral Examination forms were double key
entered as required by study procedures.
II CRF/DATA Queries
A. All data queries have been resolved or explained
in the dataset (this includes full explanation of all
true data anomalies that cannot be corrected in the
database).
B. All Closeout Site Visit issues have resolved
and/or documented and the final response(s)
posted to the XACT website .
III. Reports
A. Final Trial Monitoring Reports have been stored
with the sites study documentation (either paper
or electronic version).
B. All site visit reports and site responses to reports
are completed and stored with the sites study
documentation (either paper or electronic).
C. Plans have been made for submitting ongoing
IRB submissions until the final IRB report can be
filed.
D. All documentation relating to protocol violations
(from both the site and the DCC) are stored with
the sites study documentation.
E. A list of site specific anomalies that occurred that
may have interfered with normal study flow (e.g.
earthquake, strike).
Chapter 26: Study Closeout Version 1.0 01/12/2011
Page 26-4
Complete
N/A
Notes
V. Document Storage
A. Arrangements for storage of all hard copy study
related documentation have been made.
B. Arrangements for storage of all electronic study
related documentation have been made.
The sites Principal Investigator confirms the above checklist is complete and the sites files are ready for data
lock-down.
Site PI Name
Site Study Coordinator Name
Signature(s)
//
//
Page 26-5
Appendix B
XACT DCC Closeout Time Line
A site collects its last
data point
1 month later
2 months later
3 months later
4+ months later
DCC and site work together to clean the database and resolve all queries
Page 26-6
Appendix C
X-ACT Final Monitoring Site Visit Agenda
1. Meet with Study Coordinator: This is just a brief discussion to get oriented and
determine if the site has any issues or questions that need to be addressed. It is
optional for other staff (PI, examiners, hygienists, data entry staff, etc) to be
present for this first discussion.
o Overview of todays site visit plan
o Discussion of current issues/concerns
Final visits
Study procedures
Staffing concerns
Adverse Events
Drug Accountability and treatment application
2. Review Final Regulatory Documentation
o IRB materials and documentation
o Protocol documentation
o Forms and MOP binders
o Training documentation
3. Review Participant charts
o Review newly collected data for charts that were reviewed at previous
visits
o Finish reviewing all consent charts, if not already complete
4. Review mint accountability records
5. Review supplies
o Storage of supplies
o Final record keeping related to supplies and destruction
6. Debriefing session with PI and Study Coordinator
During the visit: The DCC monitors will want to meet briefly with the Study Coordinator
to go over any current issues or concerns. The majority of the visit will be spent
reviewing the regulatory documentation and both the consent and research charts. The
DCC monitor will need a private area with a table and seating for two monitors. A
debriefing meeting with the Study Coordinator, at a minimum, will be held at the end of
the visit to go over any issues or concerns that the monitor may have.
Following the visit: The DCC monitors will complete a detailed monitoring visit report
within two weeks of the site visit. The report is due within one month of the monitoring
visit. Copies of the monitoring visit report will be distributed via the secure XACT
website. Copies will be made available to relevant site staff, the XACT administrative
chair, the DCC, and the XACT Project Officer. The site PI or designee must respond to
the monitoring report, showing resolution of all issues, within one month of receipt.
Page 26-7
Appendix D
DCC Closeout Checklist
To be completed by DCC Data Manager
Protocol Title:
Study Type:
Behavioral
Medication
Combination
Other
Marking Complete means that all versions of the following essential documents are present and up-to-date or items are completed as
stated
Marking N/A means that the listed item is Not Applicable for the Protocol (if marked, explain why in the Notes section)
Complete
N/A
Notes
I CRF/DATA Completeness
A. All data collection is completed through
the last participants last follow-up.
B. All CRFs are complete, including data
that requires transcription from source
materials.
C. All data has been entered into the DEMS
or sent to the DCC (including any site
data that is analyzed off-site, e.g. urine
data files).
D. All collected data are entered in one or
more data files (including screen fail data
where collected, baseline records, in
treatment records, final visit/tx-end
records, and all follow-up points).
E. All missing records (CRFs) have been
verified as truly missing (e.g. not
collected).
Chapter 26: Study Closeout Version 1.0 01/12/2011
Page 26-8
Complete
N/A
Notes
II CRF/DATA Accuracy
A. There are no duplicate records in the data
files.
B. All range checks were performed (as
specified in the Data Dictionaries).
C. All within-form consistency checks
between items were performed (as
specified in the Data Dictionaries).
D. All cross-form consistency checks for
critical and repeated items were
performed (as specified in the Data
Dictionaries).
E. All outside data files (e.g. urinalysis
results files) have been checked for
accuracy and consistency.
III CRF/DATA Queries
A. All queries have been resolved or
explained in the data set.
B. All DCC Closeout visits have been
completed.
IV. Reports
A. Summarized or Aggregated Report of
Participant Recruitment, Progress, and
Chapter 26: Study Closeout Version 1.0 01/12/2011
Page 26-9
Complete
B.
F.
G.
H.
I.
J.
K.
L.
M.
N.
N/A
Notes
Retention.
A list by follow-up point of all
participants that did not complete each
follow-up visit with a reason why (e.g.
Never Showed, In Jail, Asked never to be
contacted again, etc.).
Summarized or Aggregated Report of the
CRF Completeness.
Include a list, by CRF, of all participants
missing the CRF with a reason why (e.g.
Participant Never Showed for
appointment, Participant left early, etc.).
Summarized or Aggregated Report of the
errors triggered during chart review, at
time of entry and nightly.
Summarized or Aggregated Report of the
Data Audit Reports by CRF.
A Report of Protocol Violations This
report would summarize each violation
and describe the process for resolution, if
necessary.
A Summarized Report of any data
anomalies that exist in the clean
database. The report must include
information that would uniquely identify
the record or records affected.
A list of site specific anomalies that
occurred that may have interfered with
normal study flow (e.g. earthquake,
strike).
A report listing the final timelines of data
entry for all forms.
Final adverse events reports to
Page 26-10
Complete
N/A
Notes
The Data Coordinating Center Data Management team confirms the above checklist is complete and the data
files are ready for data lock-down.
DCC PIs Name
DCC Biostatisticians name
Technical Directors
Data Managers Name
Signature(s)
//
//
//
//
Page 26-11
Appendix E
X-ACT
Database ReLocking Form
Date of
Site
U
n
l
o
c
k
Date of
Relock
Signatures
Site PI:
DCC PI:
DCC Data Manager:
DCC Biostatistician:
Site PI:
DCC PI:
DCC Data Manager:
DCC Biostatistician:
Site PI:
DCC PI:
DCC Data Manager:
DCC Biostatistician::
Page 26-12